title: Interleukin-1alpha, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation.
abstract: BACKGROUND
  The purpose was to determine the prognostic value of interleukin (IL) 1-alpha, IL-6 and IL-8 in cervico/vaginal secretion for preterm birth (<37 weeks of gestation) in twin pregnancies.
  
  
  METHODS
  The study included screening of 121 women with twin pregnancies with sampling at 24, 26, 28, 30, 32 and 34 weeks of gestation. IL-1alpha, IL-6 and IL-8 was analyzed with ELISA immunoassays. The detection limit was 30 pg/mL for IL-1 and IL-8 and 40 pg/mL for IL-6. Vaginal fluid was smeared and dried for later evaluation of bacterial vaginosis (presence of clue cells).
  
  
  RESULTS
  Spontaneous preterm birth occurred in 36 women and 65 women were delivered at term. IL-8 was significantly higher (p=0.03) in samples from women delivered preterm (median 3.72 ng/g mucus, range <0.07-220.00) compared with samples from women delivered at term (median 3.03 ng/g mucus, range <0.08-378.60). At 28 weeks of gestation, IL-8 (cut off 1.75 ng/g mucus) was associated with preterm delivery (relative risk 2.2, CI 95% 1.1-4.5) with a sensitivity, specificity, positive and negative predictive value of 78.8, 45.8, 44.8 and 79.4%, respectively. The levels of IL-1alpha and IL-6 were not significantly associated with preterm birth. Bacterial vaginosis was found in 47/541 (8.7%) samples analyzed. The levels of IL-1alpha and IL-8 were significantly higher in samples positive for bacterial vaginosis than in negative samples (p<0.0001 and p<0.01, respectively). There was no significant association between the level of IL-6 and bacterial vaginosis.
  
  
  CONCLUSIONS
  IL-8, but not IL-1alpha and IL-6, was associated with preterm delivery but the relationship was too weak to be of predictive value for preterm birth in twin pregnancies. IL-1alpha and IL-8, but not IL-6, were associated with bacterial vaginosis.
authors.affiliation: Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: U B
authors.initials: UB
authors.lastname: Wennerholm
authors.forename: B
authors.initials: B
authors.lastname: Holm
authors.forename: I
authors.initials: I
authors.lastname: Mattsby-Baltzer
authors.forename: T
authors.initials: T
authors.lastname: Nielsen
authors.forename: J J
authors.initials: JJ
authors.lastname: Platz-Christensen
authors.forename: G
authors.initials: G
authors.lastname: Sundell
authors.forename: H
authors.initials: H
authors.lastname: Hagberg
mesh_terms: D000328:Adult; D002584:Cervix Uteri / Q000276:immunology* / Q000378:metabolism; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007375:Interleukin-1 / Q000032:analysis*; D015850:Interleukin-6 / Q000032:analysis*; D016209:Interleukin-8 / Q000032:analysis*; D008875:Middle Aged; D007752:Obstetric Labor, Premature / Q000276:immunology*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000453:epidemiology; D011272:Pregnancy, Multiple / Q000276:immunology*; D012372:ROC Curve; D012680:Sensitivity and Specificity; D014621:Vagina / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D016585:Vaginosis, Bacterial / Q000175:diagnosis
chemical_list: D007375:Interleukin-1; D015850:Interleukin-6; D016209:Interleukin-8